171 related articles for article (PubMed ID: 28228232)
21. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Zhang C; Wang YE; Zhang P; Liu F; Sung CJ; Steinhoff MM; Quddus MR; Lawrence WD
Hum Pathol; 2010 Feb; 41(2):255-61. PubMed ID: 19896693
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors.
Farinola MA; Gown AM; Judson K; Ronnett BM; Barry TS; Movahedi-Lankarani S; Vang R
Int J Gynecol Pathol; 2007 Oct; 26(4):375-82. PubMed ID: 17885486
[TBL] [Abstract][Full Text] [Related]
23. A systematic review and meta-analysis of hormone receptor expression in low-grade serous ovarian carcinoma.
Voutsadakis IA
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():172-178. PubMed ID: 33246201
[TBL] [Abstract][Full Text] [Related]
24. Quantification of ER/PR expression in ovarian low-grade serous carcinoma.
Escobar J; Klimowicz AC; Dean M; Chu P; Nation JG; Nelson GS; Ghatage P; Kalloger SE; Köbel M
Gynecol Oncol; 2013 Feb; 128(2):371-6. PubMed ID: 23103384
[TBL] [Abstract][Full Text] [Related]
25. Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers.
Yan M; Rayoo M; Takano EA; ; Fox SB
Breast Cancer Res Treat; 2011 Apr; 126(2):395-405. PubMed ID: 20490651
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical expression and prognostic significance of oestrogen receptor-alpha, oestrogen receptor-beta, and progesterone receptor in stage 1 adult-type granulosa cell tumour of the ovary.
Hutton SM; Webster LR; Nielsen S; Leung Y; Stewart CJ
Pathology; 2012 Dec; 44(7):611-6. PubMed ID: 23149378
[TBL] [Abstract][Full Text] [Related]
27. Estrogen receptors alpha and beta (ERalpha and ERbeta) and androgen receptor (AR) in human sperm: localization of ERbeta and AR in mitochondria of the midpiece.
Solakidi S; Psarra AM; Nikolaropoulos S; Sekeris CE
Hum Reprod; 2005 Dec; 20(12):3481-7. PubMed ID: 16123086
[TBL] [Abstract][Full Text] [Related]
28. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
29. Expression of estrogen-responsive finger protein (Efp) is associated with advanced disease in human epithelial ovarian cancer.
Sakuma M; Akahira J; Suzuki T; Inoue S; Ito K; Moriya T; Sasano H; Okamura K; Yaegashi N
Gynecol Oncol; 2005 Dec; 99(3):664-70. PubMed ID: 16140366
[TBL] [Abstract][Full Text] [Related]
30. Hormone receptors as a marker of poor survival in epithelial ovarian cancer.
van Kruchten M; van der Marel P; de Munck L; Hollema H; Arts H; Timmer-Bosscha H; de Vries E; Hospers G; Reyners A
Gynecol Oncol; 2015 Sep; 138(3):634-9. PubMed ID: 26115976
[TBL] [Abstract][Full Text] [Related]
31. Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer.
Yan S; Dey P; Ziegler Y; Jiao X; Kim SH; Katzenellenbogen JA; Katzenellenbogen BS
Breast Cancer Res Treat; 2021 Jan; 185(2):281-292. PubMed ID: 33001337
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of ERalpha, PR and ERbeta isoforms in neoadjuvant treated breast cancer.
Wurster M; Ruoff A; Meisner C; Seeger H; Vogel U; Juhasz-Böss I; Solomayer E; Wallwiener D; Fehm T; Neubauer H
Oncol Rep; 2010 Sep; 24(3):653-9. PubMed ID: 20664970
[TBL] [Abstract][Full Text] [Related]
34. Expression of estrogen receptor beta wt isoform (ERbeta1) and ERbetaDelta5 splice variant mRNAs in sporadic breast cancer.
Mandusić V; Nikolić-Vukosavljević D; Tanić N; Kanjer K; Neskovic-Konstantinović Z; Celeketić D; Dimitrijević B
J Cancer Res Clin Oncol; 2007 Aug; 133(8):571-9. PubMed ID: 17457609
[TBL] [Abstract][Full Text] [Related]
35. Loss of p16INK4A expression in low-grade ovarian serous carcinomas.
Schlosshauer PW; Deligdisch L; Penault-Llorca F; Fatemi D; Qiao R; Yao S; Pearl M; Yang Z; Sheng T; Dong J
Int J Gynecol Pathol; 2011 Jan; 30(1):22-9. PubMed ID: 21131838
[TBL] [Abstract][Full Text] [Related]
36. Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma.
Suzuki F; Akahira J; Miura I; Suzuki T; Ito K; Hayashi S; Sasano H; Yaegashi N
Cancer Sci; 2008 Dec; 99(12):2365-72. PubMed ID: 19032364
[TBL] [Abstract][Full Text] [Related]
37. Different action of 2,2',4,4'-tetrabromodiphenyl ether (BDE-47) and its hydroxylated metabolites on ERα and ERβ gene and protein expression.
Karpeta A; Ptak A; Gregoraszczuk EŁ
Toxicol Lett; 2014 Aug; 229(1):250-6. PubMed ID: 24956591
[TBL] [Abstract][Full Text] [Related]
38. The association between reproductive and hormonal factors and ovarian cancer by estrogen-α and progesterone receptor status.
Shafrir AL; Rice MS; Gupta M; Terry KL; Rosner BA; Tamimi RM; Hecht JL; Tworoger SS
Gynecol Oncol; 2016 Dec; 143(3):628-635. PubMed ID: 27720231
[TBL] [Abstract][Full Text] [Related]
39. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer.
Sasaki M; Tanaka Y; Perinchery G; Dharia A; Kotcherguina I; Fujimoto Si; Dahiya R
J Natl Cancer Inst; 2002 Mar; 94(5):384-90. PubMed ID: 11880477
[TBL] [Abstract][Full Text] [Related]
40. Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues.
Bozkurt KK; Kapucuoğlu N
Pathol Res Pract; 2012 Mar; 208(3):133-9. PubMed ID: 22336175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
